COMMUNIQUÉS West-GlobeNewswire

Actinium Pharmaceuticals Launches the AWE Program aka Actinium Warhead Enabling Program to Enable Collaborations Based on Its Actinium-225 Technology Platform
14/11/2017
- AWE Program launched post successful demonstration of Actinium’s “Biobetter” capabilities as evidenced by superior experimental results with actinium-225 labeled daratumumab when compared to unlabeled daratumumab, a [...]
Former General Mills Executive Joins Canadian Startup as Advisor
14/11/2017
PETERBOROUGH, Ontario, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Noblegen Inc. (“Noblegen”) — announces the appointment of distinguished industry veteran, Jim Kirkwood, as an official advisor to the Corporation. Kirkwood is a [...]
Intra-Cellular Therapies Presents Data on Mechanism of Action of Lumateperone and ITI-214 at the 2017 Society for Neuroscience (SfN) Annual Meeting
14/11/2017
NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission
14/11/2017
Santa Monica, CA, Nov. 14, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results
14/11/2017
Completed Successful EMA Meeting for DCCR in Prader-Willi Syndrome Continued Preparations to Begin Phase III Program Presented Positive Updated Safety and Efficacy Data from Pilot Clinical Trial of DCCR for Treatment of [...]
Zogenix to Present at Stifel 2017 Healthcare Conference
14/11/2017
EMERYVILLE, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that [...]
ProQR Prices Approximately $20 Million Underwritten Public Offering and Concurrent Registered Direct Offering of Ordinary Shares
14/11/2017
LEIDEN, The Netherlands, Nov. 14, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR ), a biopharmaceutical company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
Zynerba Pharmaceuticals Reports Third Quarter 2017 Financial Results and Operational Highlights
14/11/2017
DEVON, Pa., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. (NASDAQ: ZYNE ), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically- [...]
XBiotech Announces Presentation of Novel Findings for MABp1 in the Prevention of Coronary Thrombosis at the American Heart Association Scientific Sessions
14/11/2017
AUSTIN, Texas, Nov. 14, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT ) announced today a presentation of findings on the role of IL-1 alpha (IL-1α) associated with Neutrophil Extracellular Traps (NETs) in [...]
Cesca Therapeutics to Present at the Advanced Cell Therapy Shanghai Summit 2017
14/11/2017
RANCHO CORDOVA, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that [...]
Strongbridge Biopharma plc Provides Corporate Update and Reports Third Quarter 2017 Financial Results
14/11/2017
~ Achieved Net Product Sales of $2.5 Million for KEVEYIS ® (dichlorphenamide) , a 67% Revenue Growth Increase over the Previous Quarter ~ ~ Increasing Commercial Investment in KEVEYIS with Expansion of Sales Force and [...]
ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update
14/11/2017
- All Three Development Compounds Progressing with Key Clinical Milestones Over the Next 12 Months - Geneva, Switzerland and Boston, MA - November 14, 2017 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical [...]
AxoGen, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference
14/11/2017
ALACHUA, Fla., Nov. 14, 2017 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej [...]
VBL Therapeutics Announces Third Quarter 2017 Financial Results
14/11/2017
Conference Call and Webcast at 8:30am Eastern Time Today TEL AVIV, Israel, Nov. 14, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT ), a clinical-stage biotechnology company focused on the discovery, development [...]
Pluristem Reports First Quarter Fiscal 2018 Corporate and Financial Highlights
14/11/2017
HAIFA, Israel, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq: PSTI ) (TASE: PSTI ), a leading developer of placenta-based cell therapy products, today reported financial results and corporate [...]
Loxo Oncology Announces Global Development and Commercialization Partnership with Bayer for Larotrectinib and LOXO-195
14/11/2017
– Up to $1.55B in Upfront, Regulatory, and Commercial Milestones – – Loxo Oncology and Bayer to Co-Promote in U.S. with a 50/50 Profit Share; Bayer to Commercialize ROW – – Loxo Oncology to Lead Global Development [...]
Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2017 Financial Results and Corporate Highlights
14/11/2017
-Presented Updated Clinical Data from Ongoing Phase 1 Trial of DCC-2618 at ESMO- -Completion of Initial Public Offering Raising Net Proceeds of $129 million- -Announced Plans to Initiate Two Pivotal Trials of DCC-2618 [...]
UroGen Pharma Reports Third Quarter 2017 Financial Results and Recent Corporate Developments
14/11/2017
RA’ANANA, Israel and NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]
Akers Biosciences’ UK Distributor Secures New Channel for Rapid Alcohol Breathalyzer
14/11/2017
Distributor Accutest Now Selling Through Today’s Group THOROFARE, N.J, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health [...]

Pages